A Clinical Trial on Diabetic Foot Using Peripheral Blood Derived Stem Cells for Treating Critical Limb Ischemia
Phase 1
- Conditions
- Diabetic FootCritical Limb IschemiaLeg Ulcers
- Interventions
- Procedure: will receive G-CSF and peripheral blood derived mononuclear cellsDrug: Standard Therapy
- First Posted Date
- 2009-06-17
- Last Posted Date
- 2009-06-17
- Lead Sponsor
- Beike Biotech India Pvt.ltd
- Target Recruit Count
- 36
- Registration Number
- NCT00922389
- Locations
- 🇮🇳
Fortis FLT.LT.Rajan Dhall Hospital, New Delhi, Delhi, India
© Copyright 2025. All Rights Reserved by MedPath